Risk Of Bleeding Among Cangrelor-treated Patients Administered Upstream P2y12 Inhibitor Therapy

Sunday, February 26, 2023

11:00 AM – 11:08 AM ET

Speaker(s)

JR

Jennifer Rymer, MD

Interventional cardiologist
Duke, North Carolina, United States

Disclosure(s): Chiesi USA: Consultant/Advisory Board (Ongoing), Contracted Research (Principal Investigators must provide information, even if received by the institution) (Ongoing); idorsia: Contracted Research (Principal Investigators must provide information, even if received by the institution) (Ongoing); Pfizer: Contracted Research (Principal Investigators must provide information, even if received by the institution) (Ongoing)

Disclosure(s):

Jennifer Rymer, MD: Chiesi USA: Consultant/Advisory Board (Ongoing), Contracted Research (Principal Investigators must provide information, even if received by the institution) (Ongoing); idorsia: Contracted Research (Principal Investigators must provide information, even if received by the institution) (Ongoing); Pfizer: Contracted Research (Principal Investigators must provide information, even if received by the institution) (Ongoing)